- Report
- March 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- January 2025
- 153 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- January 2025
- 147 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- October 2023
- 179 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2024
- 98 Pages
Global
From €3500EUR$3,929USD£3,035GBP
Polymer Based Solubility Enhancement Excipients are a type of pharmaceutical intermediate used to improve the solubility of active pharmaceutical ingredients (APIs). These excipients are typically polymers, such as polyvinylpyrrolidone (PVP), polyethylene glycol (PEG), and hydroxypropyl methylcellulose (HPMC). They are used to increase the solubility of APIs in aqueous solutions, allowing for more efficient absorption and bioavailability. Polymer Based Solubility Enhancement Excipients are also used to improve the stability of APIs, reduce the risk of precipitation, and improve the taste and mouthfeel of the final product.
Some companies in the Polymer Based Solubility Enhancement Excipients market include BASF, Evonik, Dow, Ashland, Lubrizol, and Colorcon. Show Less Read more